Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia

被引:62
作者
Koivula, Irma [1 ]
Hamalainen, Sari
Jantunen, Esa [2 ]
Pulkki, Kari [3 ,4 ]
Kuittinen, Taru
Nousiainen, Tapio
Juutilainen, Auni [2 ]
机构
[1] Kuopio Univ Hosp, Dept Med, Div Infect Dis 4620, Kuopio 70211, Finland
[2] Univ Eastern Finland, Inst Clin Med Internal Med, Kuopio, Finland
[3] Univ Eastern Finland, Dept Clin Chem, Kuopio, Finland
[4] Eastern Finland Lab Ctr, Kuopio, Finland
关键词
Procalcitonin; C-reactive protein; neutropenic fever; sepsis; bacteraemia; C-REACTIVE PROTEIN; ACUTE MYELOID-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; SEVERE SYSTEMIC INFECTION; SERUM PROCALCITONIN; POSITIVE BACTERIA; CANCER-PATIENTS; FEVER; ETIOLOGY; MARKERS;
D O I
10.3109/00365548.2011.554855
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
Objective: To compare semi-quantitative procalcitonin with C-reactive protein in predicting bacteraemia in haematological patients with neutropenic fever. Methods: A total of 77 patients treated with intensive chemotherapy for haematological malignancy at Kuopio University Hospital were candidates for study entry. Eleven of these patients did not fulfil the criteria for neutropenic fever, and 66 patients were finally included. Nineteen patients had acute myeloid leukaemia and 47 had received high-dose chemotherapy supported by autologous stem cell transplant. Ninety neutropenic fever episodes in these 66 patients fulfilled the study entry criteria, with microbiological cultures, procalcitonin and C-reactive protein measurements available. Serum procalcitonin and C-reactive protein were analyzed at the onset of each neutropenic fever episode on day 0, and then daily from days 1 to 4. Results: Bacteraemia was observed in 21 episodes (23%) and the criteria for severe sepsis were fulfilled in 13 episodes (14%). Half of the bacteraemic episodes were caused by Gram-negative bacteria. The kinetics of procalcitonin and C-reactive protein were similar, with increasing levels for 2 to 4 days after the onset of fever. The procalcitonin level on days 1, 2, 3 and 4 was associated with bacteraemia and Gram-negative bacteraemia, but not with the development of severe sepsis. On day 1, a procalcitonin level above 0.5 ng/ml had a sensitivity of 57% and 70% and specificity of 81% and 77% to predict bacteraemia and Gram-negative bacteraemia, respectively. Conclusions: An elevated level of procalcitonin within 24 h after the onset of neutropenic fever predicts bacteraemia and Gram-negative bacteraemia in haematological patients.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 34 条
[1]
Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation [J].
Blijlevens, NMA ;
Donnelly, JP ;
Meis, JFGM ;
De Keizer, MH ;
De Pauw, BE .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (06) :889-892
[2]
DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[3]
Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria [J].
Charles, Pierre Emmanuel ;
Ladoire, Sylvain ;
Aho, Serge ;
Quenot, Jean-Pierre ;
Doise, Jean-Marc ;
Prin, Sebastien ;
Olsson, Niels-Olivier ;
Blettery, Bernard .
BMC INFECTIOUS DISEASES, 2008, 8 (1)
[4]
Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria [J].
Elson, Greg ;
Dunn-Siegrist, Irene ;
Daubeuf, Bruno ;
Pugin, Jerome .
BLOOD, 2007, 109 (04) :1574-1583
[5]
Engel A, 1999, SCAND J INFECT DIS, V31, P185, DOI 10.1080/003655499750006254
[6]
Erten Nilgun, 2004, J Chin Med Assoc, V67, P217
[7]
Evaluation of infectious etiology and prognostic risk factors of febrile episodes in neutropenic cancer patients [J].
Gençer, S ;
Salepçi, T ;
Özer, S .
JOURNAL OF INFECTION, 2003, 47 (01) :65-72
[8]
Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein [J].
Hamalainen, Sari ;
Juutilainen, Auni ;
Kuittinen, Taru ;
Nousiainen, Tapio ;
Matinlauri, Irma ;
Pulkki, Kari ;
Koivula, Irma ;
Jantunen, Esa .
LEUKEMIA & LYMPHOMA, 2010, 51 (06) :1040-1046
[9]
Serum vascular endothelial growth factor in adult haematological patients with neutropenic fever: a comparison with C-reactive protein [J].
Hamalainen, Sari ;
Juutilainen, Auni ;
Matinlauri, Irma ;
Kuittinen, Taru ;
Ruokonen, Esko ;
Koivula, Irma ;
Jantunen, Esa .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (03) :251-257
[10]
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Bow, EJ ;
Brown, AE ;
Calandra, T ;
Feld, R ;
Pizzo, PA ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :730-751